2型糖尿病患者血清高敏C反应蛋白与大血管病变的相关性研究被引量：8

Relationship between Serum Hypersensitivity C-Reactive Protein and Macrovascular Diseases in Type 2 Diabetic Patients

下载PDF

导出

摘要目的探讨2型糖尿病患者血清高敏C反应蛋白(hsC-RP)与大血管病变的关系。方法选择2型糖尿病患者68例,其中2型糖尿病并发大血管病变组(A组)36例,无大血管病变组(B组)32例,并选择30例健康者为对照组(C组)。分别测定3组患者血清hsC-RP水平。结果A组和B组血清hsC-RP水平均高于C组,A组明显高于B组。结论血清hsC-RP水平的检测对预测2型糖尿病大血管病变的发生发展有重要的临床意义。 Objective To explore the relationship between hypersensitivity C-reactive protein （hsC-RP） and diabetic macrovascular diseases. Methods 68 cases with type 2 diabetes were divided into two group ： Group A （ n = 36） was with macrovascular complication and Group B （n = 32） without. 30 healthy subjects were selected as control （Group C）. The serum hsC-RP was determined by immunoturbidimetry. Results The level of hsC-RP in group A was significantly higher than that in group B and C. Conclusions The hsC-RP may play an important role in the pathogenesis of diabetes mellitus and its macrovascular complication and can be applied to predict the development of macrovascular diseases as an early predicator.

作者陶少平周蓓杭宇陈学峰

机构地区皖南医学院第二附属医院内分泌科

出处《实用全科医学》 2007年第8期672-673,共2页 Applied Journal Of General Practice

关键词糖尿病 2型 C反应蛋白大血管病变 Diabetes mellitus Type 2 C-reactive protein Macroangiopathy

分类号 R587.1 [医药卫生—内分泌] R543.5 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献1

1李秀钧,邬云红.糖尿病是一种炎症性疾病?[J].中华内分泌代谢杂志,2003,19(4):251-253. 被引量：253

二级参考文献17

1Schmidt MI, Duncan BB, Scharrct AR, et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet, 1999,353:1649-1652.
2Barzilay JI, Abraham L, Heckbert SR, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes, 2001,50:2384-2389.
3Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA, 2001,286:327-334.
4Festa A, Ralph BD, Russell PT, et al. Elevated levels of acute phase proteins and plasminogen activator inhibitor-1 (PAI-1) predict the development of type 2 diabetes mellitus: the insulin resistance atherosclerosis study (IRAS). Diabetes, 2000,49(Suppl 1):A24-A25.
5Duncan BB, Schmidt MI, Offenbacher S, et al. Factor Ⅷ and other hemostasis variables are related to incident diabetes in adults. Diabetes care, 1999,22:767-772.
6Lindsay RS, Krakoff J, Hanson RL, et al. Gamma globulin levels predict type 2 diabetes in the Pima Indian population. Diabetes, 2001,50:1598-1603.
7Mcneely MJ, Bokyko EJ, Weigle DS, et al. Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans. Diabetes Care, 1999,22:65-70.
8Yuan M, Konstantopoulos N, Lee J, et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKKbeta. Science, 2001,293:1673-1677.
9Hundal RS, Petersen KF, Mayerson AB, et al. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest, 2002,109:1321-1326.
10Freeman DJ, Norrie J, Sattar N, et al. Pravastatin and the development of diabetes mellitus, evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study. Circulation, 2001,103:357-362.